Supplier Type
- Trader
- Reagent
- Manufacturer
- contract manufacturer
- custom synthesis
Supplier Region
- Maharashtra(18)
- Delhi(12)
- Beijing(2)
- Andhra Pradesh(1)
- Gujarat(20)
- Mumbai(54)
- Hyderabad(10)
- Bangalore(1)
- Pune(4)
- Telangana(1)
- Karnataka(4)
- Ahmedabad(8)
- Vadodara(4)
- Uttar Pradesh(4)
- Haryana(1)
- Kolkata(3)
- Nagpur(1)
- Tamil Nadu(1)
- New Delhi(1)
- West Bengal(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.9 % min.
- 99.9
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.5%
- 99.42%
- 99.29%
- 99%
- > 99%
- >99%
- 98.60%
- 98.12%
- 98.0 % - 102.0 %
- 98% Min
- 98%
- 97-99%
- 97.57%
- 97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95.00%
- 95%
- >95%
- 94.00%
- >92%
- >90%
- 90%
- 90 % Above
- 40%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1gm
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Ethylene glycol
107-21-1
-
C.I. Reactive orange 107
90597-79-8
-
Allyl alcohol
107-18-6
-
Acid Black 107
12218-96-1
-
2-Cyanoacetamide
107-91-5
-
Allyl chloride
107-05-1
-
Ethylenediamine
107-15-3
-
1,2-Dichloroethane
107-06-2
-
Butyric Acid
107-92-6
-
β-Alanine
107-95-9
Ethyleneglycol 107-21-1
Ethyleneglycol 107-21-1
Reactive orange 107 90597-79-8
Allyl Alcohol 107-18-6
Acid black 107 12218-96-1
2-Cyanoacetamide 107-91-5
Ethylenediamine 107-15-3
Ethylene dichloride 107-06-2
Ethylene dichloride 107-06-2
Ethylenediamine 107-15-3

